trifluperidol has been researched along with preclamol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fiechtner, B; Glossmann, H; Hoffmann, RD; Laggner, C; Langer, T; Moebius, FF; Poles, G; Schieferer, C | 1 |
| Hariton, C | 1 |
2 other study(ies) available for trifluperidol and preclamol
| Article | Year |
|---|---|
Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening.
Topics: Animals; Carrier Proteins; Databases, Factual; Guinea Pigs; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Isomerism; Ligands; Models, Molecular; Quantitative Structure-Activity Relationship; Radioligand Assay; Receptors, sigma; Saccharomyces cerevisiae; Sigma-1 Receptor; Steroid Isomerases | 2005 |
Ocular hypotension induced by topical dopaminergic drugs and phosphodiesterase inhibitors.
Topics: Administration, Topical; Animals; Dopamine Agents; Glucose; Male; Ocular Hypotension; Ophthalmic Solutions; Pentoxifylline; Phosphodiesterase Inhibitors; Piperidines; Rabbits; Stereoisomerism; Trifluperidol; Xanthines | 1994 |